Plasmodium falciparum: DNA sequence specificity of cisplatin and cisplatin analogues

被引：5

作者：

Murray, Vincent ^{[1
]}

Campbell, Heather M. ^{[1
]}

Gero, Annette M. ^{[1
]}

机构：

[1] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia

来源：

EXPERIMENTAL PARASITOLOGY | 2011年 / 128卷 / 04期

基金：

英国医学研究理事会;

关键词：

Malaria; Transplatin; Carboplatin; Repeat sequence; DNA-targeted analogues; PLATINUM COMPLEXES; MALARIA; CIS-DIAMMINEDICHLOROPLATINUM(II); AGENTS; CARBOPLATIN; COMBINATION; DERIVATIVES; SELECTIVITY; POLYMERASE; RESISTANCE;

D O I：

10.1016/j.exppara.2011.05.002

中图分类号：

R38 [医学寄生虫学]; Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ; 100103 ;

摘要：

In this paper, we provided evidence that cisplatin is able to form adducts with cellular DNA in Plasmodium falciparum. The DNA sequence specificity of cisplatin adduct formation was determined in trophozoite-enriched P. falciparum cells and this paper represents the first occasion that the sequence specificity of cisplatin DNA damage has been observed in malaria cells. Utilising a sub-telomeric, 692 bp repeat sequence in the P. falciparum genome, we were able to investigate the DNA adducts formed by cisplatin and five analogues. A run of eight consecutive guanines was the most prominent site of DNA damage in the malarial cells. This study suggests that the mechanism of P. falciparum cell death caused by cisplatin involves damage to DNA and hence inhibition of DNA replication and cell division. (C) 2011 Elsevier Inc. All rights reserved.

引用

页码：396 / 400

页数：5

共 50 条

[1] DNA sequence selectivity of cisplatin analogues in intact human cells
Murray, V
Whittaker, J
McFayden, WD
CHEMICO-BIOLOGICAL INTERACTIONS, 1998, 110 (1-2) : 27 - 37
[2] Plasmodium falciparum: The potential of the cancer chemotherapeutic agent cisplatin and its analogues as anti-malarials
Murray, Vincent
Campbell, Heather M.
Gero, Annette M.
EXPERIMENTAL PARASITOLOGY, 2012, 132 (04) : 440 - 443
[3] The interaction of cisplatin and analogues with DNA in reconstituted chromatin
Galea, AM
Murray, V
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2002, 1579 (2-3): : 142 - 152
[4] The sequence selectivity of DNA-targeted 9-aminoacridine cisplatin analogues in a telomere-containing DNA sequence
Paul, Moumita
Murray, Vincent
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2011, 16 (05): : 735 - 743
[5] The sequence selectivity of DNA-targeted 9-aminoacridine cisplatin analogues in a telomere-containing DNA sequence
Moumita Paul
Vincent Murray
JBIC Journal of Biological Inorganic Chemistry, 2011, 16
[6] Chiral differentiation of DNA adducts formed by enantiomeric analogues of antitumor cisplatin is sequence-dependent
Delalande, O
Malina, J
Brabec, V
Kozelka, J
BIOPHYSICAL JOURNAL, 2005, 88 (06) : 4159 - 4169
[7] Cisplatin Analogues with an Increased Interaction with DNA: Prospects for Therapy
Hardie, Megan E.
Kava, Hieronimus W.
Murray, Vincent
CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (44) : 6645 - 6664
[8] The DNA sequence selectivity of maltolato-containing cisplatin analogues in purified plasmid DNA and in intact human cells
Cairns, Murray J.
Carland, Michael
McFadyen, W. David
Denny, William A.
Murray, Vincent
JOURNAL OF INORGANIC BIOCHEMISTRY, 2009, 103 (08) : 1151 - 1155
[9] SEQUENCE SPECIFICITY OF DNA-DNA INTERSTRAND CROSS-LINK FORMATION BY CISPLATIN AND DINUCLEAR PLATINUM COMPLEXES
ZOU, Y
VANHOUTEN, B
FARRELL, N
BIOCHEMISTRY, 1994, 33 (18) : 5404 - 5410
[10] Interaction of 11 cisplatin analogues with DNA: characteristic pattern of damage with monofunctional analogues
Murray, V
Whittaker, J
Temple, MD
McFadyen, WD
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1997, 1354 (03): : 261 - 271

← 1 2 3 4 5 →